182 related articles for article (PubMed ID: 29440330)
1. Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia.
Ukah UV; Payne B; Hutcheon JA; Ansermino JM; Ganzevoort W; Thangaratinam S; Magee LA; von Dadelszen P
Hypertension; 2018 Apr; 71(4):659-665. PubMed ID: 29440330
[TBL] [Abstract][Full Text] [Related]
2. External Validation of the fullPIERS Model for Predicting Adverse Maternal Outcomes in Pregnancy Hypertension in Low- and Middle-Income Countries.
Ukah UV; Payne B; Lee T; Magee LA; von Dadelszen P;
Hypertension; 2017 Apr; 69(4):705-711. PubMed ID: 28167685
[TBL] [Abstract][Full Text] [Related]
3. Placental growth factor for the prognosis of women with preeclampsia (fullPIERS model extension): context matters.
Ukah UV; Payne BA; Hutcheon JA; Chappell LC; Seed PT; Conti-Ramsden FI; Ansermino JM; Magee LA; von Dadelszen P;
BMC Pregnancy Childbirth; 2020 Nov; 20(1):668. PubMed ID: 33153436
[TBL] [Abstract][Full Text] [Related]
4. Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with pre-eclampsia.
Ukah UV; Payne B; Karjalainen H; Kortelainen E; Seed PT; Conti-Ramsden FI; Cao V; Laivuori H; Hutcheon J; Chappell L; Mark Ansermino J; Vatish M; Redman C; Lee T; Li L; Magee LA; von Dadelszen P;
Pregnancy Hypertens; 2019 Jan; 15():42-50. PubMed ID: 30825926
[TBL] [Abstract][Full Text] [Related]
5. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model.
von Dadelszen P; Payne B; Li J; Ansermino JM; Broughton Pipkin F; Côté AM; Douglas MJ; Gruslin A; Hutcheon JA; Joseph KS; Kyle PM; Lee T; Loughna P; Menzies JM; Merialdi M; Millman AL; Moore MP; Moutquin JM; Ouellet AB; Smith GN; Walker JJ; Walley KR; Walters BN; Widmer M; Lee SK; Russell JA; Magee LA;
Lancet; 2011 Jan; 377(9761):219-27. PubMed ID: 21185591
[TBL] [Abstract][Full Text] [Related]
6. Predicting complications in pre-eclampsia: external validation of the fullPIERS model using the PETRA trial dataset.
Akkermans J; Payne B; von Dadelszen P; Groen H; Vries Jd; Magee LA; Mol BW; Ganzevoort W
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():58-62. PubMed ID: 24965981
[TBL] [Abstract][Full Text] [Related]
7. Validation of fullPIERS model for prediction of adverse outcomes among women with severe pre-eclampsia.
Almeida ST; Katz L; Coutinho I; Amorim MMR
Int J Gynaecol Obstet; 2017 Aug; 138(2):142-147. PubMed ID: 28475234
[TBL] [Abstract][Full Text] [Related]
8. Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) cohort, collected on admission.
Payne B; Hodgson S; Hutcheon JA; Joseph KS; Li J; Lee T; Magee LA; Qu Z; von Dadelszen P;
BJOG; 2013 Jan; 120(1):113-8. PubMed ID: 23078362
[TBL] [Abstract][Full Text] [Related]
9. [External validation of FullPIERS model for prediction of adverse outcomes among women with pre-eclampsia in French maternity of 2014 to 2018].
Boutot M; Margueritte F; Boukeffa N; Coste Mazeau P; Aubard Y; Gauthier T
Gynecol Obstet Fertil Senol; 2020 Feb; 48(2):167-173. PubMed ID: 31923643
[TBL] [Abstract][Full Text] [Related]
10. Validation of the fullPIERS model for prediction of adverse outcomes in preeclampsia at a referral center.
Guida JP; Cralcev C; Costa Santos J; Marangoni-Junior M; Sanchez MP; Laura Costa M
Pregnancy Hypertens; 2021 Mar; 23():112-115. PubMed ID: 33310390
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of Prediction models for Risks of complications in Early-onset Pre-eclampsia (PREP): a prospective cohort study.
Thangaratinam S; Allotey J; Marlin N; Mol BW; Von Dadelszen P; Ganzevoort W; Akkermans J; Ahmed A; Daniels J; Deeks J; Ismail K; Barnard AM; Dodds J; Kerry S; Moons C; Riley RD; Khan KS
Health Technol Assess; 2017 Apr; 21(18):1-100. PubMed ID: 28412995
[TBL] [Abstract][Full Text] [Related]
12. Prediction of postpartum hemorrhage in women with gestational hypertension or mild preeclampsia at term.
Koopmans CM; van der Tuuk K; Groen H; Doornbos JP; de Graaf IM; van der Salm PC; Porath MM; Kuppens SM; Wijnen EJ; Aardenburg R; van Loon AJ; Akerboom BM; van der Lans PJ; Mol BW; van Pampus MG;
Acta Obstet Gynecol Scand; 2014 Apr; 93(4):399-407. PubMed ID: 24575790
[TBL] [Abstract][Full Text] [Related]
13. Prediction of complications of pre-eclampsia using the fullPIERS high risk predictive model.
Sharma A; Suri J; Khanam Z; Pandey D; Bachani S; Sharma A
Int J Gynaecol Obstet; 2023 Dec; 163(3):983-988. PubMed ID: 37328916
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of risk prediction models for adverse maternal and neonatal outcomes in severe preeclampsia in a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe.
Ngwenya S; Jones B; Mwembe D; Nare H; Heazell AEP
Pregnancy Hypertens; 2021 Mar; 23():18-26. PubMed ID: 33161225
[TBL] [Abstract][Full Text] [Related]
15. Early-onset preeclampsia appears to discourage subsequent pregnancy but the risks may be overestimated.
Seeho SK; Algert CS; Roberts CL; Ford JB
Am J Obstet Gynecol; 2016 Dec; 215(6):785.e1-785.e8. PubMed ID: 27457117
[TBL] [Abstract][Full Text] [Related]
16. Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models.
Thangaratinam S; Allotey J; Marlin N; Dodds J; Cheong-See F; von Dadelszen P; Ganzevoort W; Akkermans J; Kerry S; Mol BW; Moons KG; Riley RD; Khan KS;
BMC Med; 2017 Mar; 15(1):68. PubMed ID: 28356148
[TBL] [Abstract][Full Text] [Related]
17. A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study.
Payne BA; Hutcheon JA; Ansermino JM; Hall DR; Bhutta ZA; Bhutta SZ; Biryabarema C; Grobman WA; Groen H; Haniff F; Li J; Magee LA; Merialdi M; Nakimuli A; Qu Z; Sikandar R; Sass N; Sawchuck D; Steyn DW; Widmer M; Zhou J; von Dadelszen P;
PLoS Med; 2014 Jan; 11(1):e1001589. PubMed ID: 24465185
[TBL] [Abstract][Full Text] [Related]
18. Uric Acid as a predictor of adverse maternal and perinatal outcomes in women hospitalized with preeclampsia.
Livingston JR; Payne B; Brown M; Roberts JM; Côté AM; Magee LA; von Dadelszen P;
J Obstet Gynaecol Can; 2014 Oct; 36(10):870-877. PubMed ID: 25375299
[TBL] [Abstract][Full Text] [Related]
19. Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia: data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) study.
Yen TW; Payne B; Qu Z; Hutcheon JA; Lee T; Magee LA; Walters BN; von Dadelszen P;
J Obstet Gynaecol Can; 2011 Aug; 33(8):803-809. PubMed ID: 21846435
[TBL] [Abstract][Full Text] [Related]
20. PIERS proteinuria: relationship with adverse maternal and perinatal outcome.
Payne B; Magee LA; Côté AM; Hutcheon JA; Li J; Kyle PM; Menzies JM; Peter Moore M; Parker C; Pullar B; von Dadelszen P; Walters BN; ; von Dadelszen P; Magee LA; Douglas MJ; Walley KR; Russell JA; Lee SK; Gruslin A; Smith GN; Côté AM; Moutquin JM; Brown MA; Davis G; Walters BN; Sass N; Duan T; Zhou J; Mahajan S; Noovao A; McCowan LA; Kyle P; Moore MP; Bhutta SZ; Bhutta ZA; Hall ; Steyn DW; Broughton Pipkin F; Loughna P; Robson S; de Swiet M; Walker JJ; Grobman WA; Lindheimer MD; Roberts JM; Mark Ansermino J; Benton S; Cundiff G; Hugo D; Joseph KS; Lalji S; Li J; Lott P; Ouellet AB; Shaw D; Keith Still D; Tawagi G; Wagner B; Biryabarema C; Mirembe F; Nakimuli A; Tsigas E; Merialdi M; Widmer M
J Obstet Gynaecol Can; 2011 Jun; 33(6):588-597. PubMed ID: 21846448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
